Menopause marks a significant physiological transition for women, characterized by the cessation of menstruation and a natural decline in reproductive hormones, particularly estrogen. This hormonal shift is not without consequences, influencing various aspects of health including the composition and function of the microbiota across different body sites such as the gut, vaginal, and oral regions. The disruptions in microbiota associated with menopause, known as dysbiosis, may contribute to several menopause-related diseases including osteoporosis, cardiovascular disease, and certain cancers.
The Microbiota-Hormone Interplay
The human microbiota plays a pivotal role in maintaining homeostasis and health. It aids in food digestion, vitamin production, pathogen defense, and immune system modulation. Dysbiosis during menopause is influenced by the decline in estrogen, which directly affects microbial diversity and composition, leading to increased vulnerability to disease. Research highlights a bidirectional relationship between sex hormones and microbiota, where not only does hormonal change impact microbiota composition, but certain gut microbes can metabolize and thus influence circulating hormone levels, particularly estrogens.
Probiotics, Prebiotics, and Menopause-Related Diseases
The application of probiotics and prebiotics to manage dysbiosis presents a promising approach to potentially mitigate menopause-related conditions. Probiotics, which are live microorganisms, can confer health benefits when administered in adequate amounts, by aiding in the restoration of microbiota balance. Prebiotics, which are fibers that feed beneficial bacteria, can also support this balance and enhance the effectiveness of probiotics.
1. Bone Health and Osteoporosis
Probiotics may enhance intestinal calcium absorption, a critical factor in maintaining bone density post-menopause. Studies suggest that specific probiotic strains can significantly affect bone metabolism markers, potentially slowing the progression of osteoporosis. For example, Lactobacillus reuteri has been shown to reduce bone mass density loss in elderly women with osteopenia.
2. Cardiometabolic Diseases
The alteration in gut microbiota during menopause can also affect metabolic functions, influencing the risk of obesity and cardiovascular diseases. Probiotics have been observed to improve markers of endothelial dysfunction, inflammation, and metabolic health, thus potentially reducing the risk of heart disease and diabetes.
3. Breast Cancer
Emerging evidence suggests a link between gut microbiota and the risk of breast cancer. Dysbiosis may influence systemic inflammation and the metabolism of carcinogens. While direct evidence of probiotics’ effect on breast cancer risk is limited, observational studies suggest a potential protective role of fermented foods rich in probiotics.
4. Endometrial Health
Changes in the vaginal microbiota during menopause can influence the health of the endometrium. Probiotics might help maintain a healthy vaginal pH and microbial balance, potentially reducing the risk of endometrial hyperplasia and associated cancers.
Mechanisms of Action
The beneficial effects of probiotics are attributed to several mechanisms:
- Enhancing Gut Barrier Function: Probiotics can strengthen the intestinal barrier, preventing the translocation of harmful substances that might trigger inflammatory and immune responses.
- Immunomodulation: Certain probiotic strains modulate immune system responses, potentially reducing inflammation and immune-mediated damage at various body sites.
- Metabolic Activity: Probiotics can influence the metabolism of dietary components and host-produced molecules, including hormones, thus affecting overall metabolic health and disease risk.
Conclusion
Probiotics and prebiotics offer a compelling, low-risk intervention for addressing the complex changes associated with menopause. By potentially mitigating the effects of dysbiosis, they hold promise for improving life quality and health outcomes for menopausal women. Further research is crucial to fully harness their potential and integrate them effectively into menopause management strategies.
- Barrea L, Verde L, Auriemma RS, Vetrani C, Cataldi M, Frias-Toral E, Pugliese G, Camajani E, Savastano S, Colao A, Muscogiuri G. Probiotics and Prebiotics: Any Role in Menopause-Related Diseases? Curr Nutr Rep. 2023 Mar;12(1):83-97. doi: 10.1007/s13668-023-00462-3. Epub 2023 Feb 7. PMID: 36746877; PMCID: PMC9974675.
- Samanta S. Potential Impacts of Prebiotics and Probiotics on Cancer Prevention. Anticancer Agents Med Chem. 2022;22(4):605-628. doi: 10.2174/1871520621999201210220442. PMID: 33305713.
- Summer M, Sajjad A, Ali S, Hussain T. Exploring the underlying correlation between microbiota, immune system, hormones, and inflammation with breast cancer and the role of probiotics, prebiotics and postbiotics. Arch Microbiol. 2024 Mar 10;206(4):145. doi: 10.1007/s00203-024-03868-x. PMID: 38461447.
- da Silva TF, Casarotti SN, de Oliveira GLV, Penna ALB. The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts. Crit Rev Food Sci Nutr. 2021;61(2):337-355. doi: 10.1080/10408398.2020.1733483. Epub 2020 Mar 10. PMID: 32156153.
- Ballan R, Battistini C, Xavier-Santos D, Saad SMI. Interactions of probiotics and prebiotics with the gut microbiota. Prog Mol Biol Transl Sci. 2020;171:265-300. doi: 10.1016/bs.pmbts.2020.03.008. Epub 2020 Apr 24. PMID: 32475525.
- Singh V, Park YJ, Lee G, Unno T, Shin JH. Dietary regulations for microbiota dysbiosis among post-menopausal women with type 2 diabetes. Crit Rev Food Sci Nutr. 2023;63(29):9961-9976. doi: 10.1080/10408398.2022.2076651. Epub 2022 May 30. PMID: 35635755.